Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-IT101 vs Chemotherapy in Advanced Melanoma
NCT07406724Phase 2Recruiting
- Sponsor
- Huasai Biomedicine
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of HS-IT101 in melanoma, sponsored by Huasai Biomedicine. Started Feb 2026; status: recruiting.
02
Drugs
HS-IT101
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT07406724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07406724.